Prospect Medical Holdings Inc - Amended Current report filing (8-K/A)
16 Septiembre 2008 - 2:41PM
Edgar (US Regulatory)
United States
Securities
and Exchange Commission
Washington,
D.C. 20549
Form 8-K/A
Amendment No. 1
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of Report
(Date of earliest event reported):
September 2,
2008
Prospect
Medical Holdings, Inc.
(Exact name of
Registrant as specified in its charter)
Delaware
(State or other
jurisdiction of incorporation)
1-32203
|
|
33-0564370
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
10780
Santa Monica Blvd., Suite 400
|
|
|
Los Angeles, California
|
|
90025
|
(Address of
principal executive offices)
|
|
(Zip Code)
|
Registrants
telephone number, including area code:
(310)
943-4500
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 4.01
Changes in Registrants Certifying
Accountant.
On September 2,
2008, we dismissed Ernst & Young LLP (the Former Auditors) as our
independent registered public accounting firm and retained BDO Seidman, LLP
(the New Auditors) to serve as our independent registered public accounting
firm for the fiscal year ending September 30, 2008. Our Audit Committee
approved the change in auditors on August 29, 2008.
In connection with the
audits of our financial statements for the fiscal years ended September 30,
2006 and 2007, and in the subsequent interim period through September 2,
2008, the date of the dismissal of the Former Auditors, there were no
disagreements with the Former Auditors on any matter of accounting principles
or practices, financial statement disclosure or auditing scope and procedure
which, if not resolved to the satisfaction of the Former Auditors, would have
caused them to make reference to the subject matter of the disagreement in
connection with their report. Neither of
the Former Auditors reports on our consolidated financial statements for the
fiscal years ended September 30, 2006 and September 30, 2007
contained an adverse opinion or disclaimer of opinion or was qualified or
modified as to uncertainty, audit scope or accounting principles.
In connection with their
audit of our consolidated financial statements for the fiscal year ended September 30,
2007, the Former Auditors noted certain material weaknesses in our internal
control over financial reporting, which we have previously disclosed in our annual
report on Form 10-K for the year ended September 30, 2007 and in our
quarterly reports on Form 10-Q for the periods ended December 31,
2007, March 31, 2008 and June 30, 2008 (the Reports). The material
weaknesses were identified following our acquisition of Alta Hospitals System,
LLC (Alta) on August 8, 2007 and related to certain material errors in
the previously issued financial statements of Alta for its fiscal year ended December 31,
2006 and material adjustments that were required to be made to Altas interim
financial statements as of and for the six months ended June 30, 2007. As
more fully described in the Reports, the material weaknesses noted were in the
areas of recording reimbursements due from third-party payors related to open
cost report years; accounting for receivables from government disproportionate
share programs; valuation of general hospital accounts receivable balances; a
lack, at that time, of the necessary finance personnel at Alta with specific
expertise to evaluate all appropriate data and accounting considerations
related to these areas and knowledgeable personnel capable of overseeing and
evaluating work performed by outside consultants working on Altas behalf; and,
as a result of acquisitions completed in 2007, significant changes in our
corporate and financial reporting structure that resulted in our having a
multi-location, multi-tier reporting and consolidation process with
decentralized accounting functions at each of our reporting units, which
significantly taxed our finance and accounting resources existing at the time
and as a result, we did not make timely filings of our Form 10-K for the
year ended September 30, 2007 and Forms 10-Q for the quarters ended December 31,
2007 and March 31, 2008. We have authorized the Former Auditors to respond
fully to inquiries of the New Auditors concerning the subject matter of these
material weaknesses. We have also requested the Former Auditors to furnish us a
letter addressed to the Commission stating whether they agree with the above
statements. A copy of their letter dated September 16, 2008, is filed as Exhibit 99.1
to this report.
Prior to September 2,
2008, including for the fiscal years ended September 30, 2006 and 2007 and
the subsequent interim period through September 2, 2008, neither we nor
anyone acting on our behalf has consulted with the New Auditors concerning the
application of accounting principles to any specific completed or contemplated
transaction, the type of audit opinion that might be rendered on our consolidated
financial statements, or any other matter.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
The following exhibits
are filed with the Form 8-K:
Exhibit No.
|
|
Description
|
99.1
|
|
Letter of
Ernst & Young LLP dated September 16, 2008
|
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
PROSPECT MEDICAL HOLDINGS, INC.
|
|
|
|
|
|
By:
|
/s/ MIKE HEATHER
|
|
|
Mike
Heather
|
|
|
Chief
Financial Officer
|
|
|
Dated:
September 16, 2008
|
|
3
Prospect Medical (AMEX:PZZ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Prospect Medical (AMEX:PZZ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024